The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction
Titel:
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction
Auteur:
Lenhard, J. M. Lancaster, M. E. Paulik, M. A. Weiel, J. E. Binz, J. G. Sundseth, S. S. Gaskill, B. A. Lightfoot, R. M. Brown, H. R.